|Datasheet||Specific References||Reviews||Related Products||Protocols|
|Vector Type||Mammalian Expression Vector|
|Expression Method||Constiutive, Stable / Transient|
|Selection In Mammalian Cells||Hygromycin|
A myc tag can be used in many different assays that require recognition by an antibody. If there is no antibody against the studied protein, adding a myc-tag allows one to follow the protein with an antibody against the Myc epitope. Examples are cellular localization studies by immunofluorescence or detection by Western blotting.
The peptide sequence of the myc-tag is: N-EQKLISEEDL-C (1202 Da). It can be fused to the C-terminus and the N-terminus of a protein. It is advisable not to fuse the tag directly behind the signal peptide of a secretory protein, since it can interfere with translocation into the secretory pathway.
|Human TDGF1 ORF mammalian expression plasmid, C-GFPSpark tag||HG10908-ACG|
|Human TDGF1 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||HG10908-ACR|
|Human TDGF1 ORF mammalian expression plasmid, C-Flag tag||HG10908-CF|
|Human TDGF1 ORF mammalian expression plasmid, C-His tag||HG10908-CH|
|Human TDGF1 ORF mammalian expression plasmid, C-Myc tag||HG10908-CM|
|Human TDGF1 ORF mammalian expression plasmid, C-HA tag||HG10908-CY|
|Human TDGF1 Gene cDNA clone plasmid||HG10908-M|
|Human TDGF1 ORF mammalian expression plasmid, Flag tag||HG10908-M-F|
|Human TDGF1 ORF mammalian expression plasmid, N-Flag tag||HG10908-NF|
|Human TDGF1 ORF mammalian expression plasmid, N-His tag||HG10908-NH|
|Human TDGF1 ORF mammalian expression plasmid, N-Myc tag||HG10908-NM|
|Human TDGF1 ORF mammalian expression plasmid, N-HA tag||HG10908-NY|
|Human TDGF1 natural ORF mammalian expression plasmid||HG10908-UT|
|Learn more about expression Vectors|
Cripto/TDGF1 is a member of the epidermal growth factor (EGF)- Cripto, Frl-1, and Cryptic (CFC) family. EGF-CFC family member proteins share a variant EGF-like motif, a conserved cysteine-rich domain, and a C-terminal hydrophobic region. Before gastrulation, Cripto is asymmetrically expressed in a proximal–distal gradient in the epiblast, and subsequently is expressed in the primitive streak and newly formed embryonic mesoderm. These proteins play key roles in intercellular signaling pathways during vertebrate embryogenesis. Mutations in Cripto/TDGF1 can cause autosomal visceral heterotaxy. Cripto/TDGF1 is involved in left-right asymmetric morphogenesis during organ development. Cripto signalling is essential for the conversion of a proximal–distal asymmetry into an orthogonal anterior–posterior axis. The mechanism of inhibitory effects of the Cripto includes both cancer cell apoptosis, activation of c-Jun-NH(2)-terminal kinase and p38 kinase signaling pathways and blocking of Akt phosphorylation. Thus, Cripto is a unique target, and Immunohistochemistry to Cripto could be of therapeutic value for human cancers.